Delivery Order SPE2DB24D2205-SPE2DB25FDZXD

Award Date 3/20/25
Potential Completion Date 3/21/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,579.48 Firm Fixed Price Delivery Order contract is for the supply of PIMECROLIMUS 1% CREAM 100GM, a topical medication. The award is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,005.42, is a delivery order for the supply of PIMECROLIMUS 1% CREAM 60GM. The contract has a firm fixed price pricing type and an ultimate completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,033.53 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream, a topical medication. The award has an ultimate completion date of September 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.29 firm fixed price delivery order is for the supply of PIMECROLIMUS CREAM, a pharmaceutical product, with a completion date of February 22, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,469.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PIMECROLIMUS 1% CREAM 30GM, a pharmaceutical product, and has an ultimate completion date of March 20, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,835.77 Delivery Order contract is for the supply of Pimecrolimus 1% Cream 30GM, a specialty pharmaceutical product, to support military healthcare programs. The contract has a completion date of January 29, 2025 and utilizes a Firm Fixed Price pricing type. This award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $2,175.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PIMECROLIMUS 1% CREAM 30GM, a pharmaceutical product, with a completion date of December 12, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999 through November 2026. The contract provides for the delivery of a variety of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The...
This federal contract award, valued at $1,599.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PIMECROLIMUS 1% CREAM 30GM, a medical product, with a completion date of March 5, 2025. The contract is a Delivery Order and has a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FDZSP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,551.48 firm fixed-price delivery order is for the supply of 4567602351 - Pimecrolimus 1% Cream 30GM, with a completion date of March 18, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDZXD
    Delivery Order

This federal contract award, valued at $2,946.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PIMECROLIMUS 1% CREAM 30GM, a medical product, to support federal government agencies.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/19/25, 10:04 AM